维普期刊资源整合服务平台（V6.5）

1502篇 您的检索式：期刊名="Ther Drug Monit"

选中清除导出查看参考文献查看引证文献引用追踪共76页首页上一页第1页下一页末页 /76 跳转

	题名	作者	年代	出处	被引量
1	Analysis ofpregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC 显示文摘	BERRY D MILLINGTON C	2005	Ther Drug Monit2005，27，4：	1
2	Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges显示文摘	Christians U Schmitz V Schoning W	2008	Ther Drug Monit2008，30，2：	1
3	Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection 显示文摘	LE GUELLEC C BESNIER J M	2001	Ther Drug Monit2001，23，6：	1
4	Clinical pharmacoki- netic monitoring of itraconazole is warranted in only a subset of patients显示文摘	Buchkowsky SS Partovi N Ensom MH	2005	Ther Drug Monit2005，27，3：	1
5	Resistance to aspirin in pa tients after coronary artery bypass grafting is transient : impact on the mo nitoring of aspirin antiplatelet therapy 显示文摘	Golafiski J Chtopieki S Golafiski R	2005	Ther Drug Monit2005，27，4：	1
6	Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997显示文摘	REIS M LUNDMARK J BENGTSSON F	2003	Ther Drug Monit2003，25，2：	1
7	Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection显示文摘	Aravagiri M Ames D Wirshing WC	1997	Ther Drug Monit1997，19，3：	1
8	Enzyme-multiplied immunoassay digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centers显示文摘	Saccoia NC Hackett LP Mortis RG	1996	Ther Drug Monit1996，18，6：	1
9	Two-hour cyclosporing concentration determination: an appropriate tool to monitor neoral therapy显示文摘	Oellerich M Armstrong VW	2002	Ther Drug Monit2002，24，1：	1
10	Cyclosporine in whole blood drug monitoring difficulities and presentation of a reliable normal phase liquid chromatographic assay显示文摘	Poirier JM Lebot JM Cheymol G	1994	Ther Drug Monit1994，16，4：	1
11	New antiepileptic drugs currently in clinical trials:is there a strategy in their develop- ment? 显示文摘	BIALER M	2002	Ther Drug Monit2002，24，1：	1
12	Therapeutic drug monitoring of the new erantiepileptic drugs显示文摘	Johannessen S T Battino D Berry D J	2003	Ther Drug monit2003，25，3：	1
13	Phenotypic and genotypic analysis of thiopurine S-methyltransferase polymorphism in the Bulgarian population显示文摘	Atanasova S Shipkova M	2003	Ther Drug Monit2003，25，5：	1
14	Association of the CYP3A4 * 1B 5'- flanking region polymorphism with cyclosporine pharmacoki netics in the healthy subjects显示文摘	Min DI Ellingrod VL	2003	Ther Drug Monit2003，25，3：	1
15	Postmortem drug analysis:analytical and toxicological aspects显示文摘	Drummer OH Gerostamoulos J	2002	Ther Drug Monit2002，24，2：	1
16	Therapeutic drug monitoring of escitalopram in an outpatient setting显示文摘	REIS M CHERMA MD CARLSSON B	2007	Ther Drug Monit2007，29，6：	1
17	Mycophenolate mofetil for solid organ transplantation:does the evidence support the need for clinical pharmacokinetic monitoring?显示文摘	Cox VC Ensom MH	2003	Ther Drug Monit2003，25，2：	1
18	Effect of age, gender and steady state procainamide pharmacokinetics after administration of procanbid sustained-release tablets 显示文摘	Koup J R Abel R B Smithers J A	1998	Ther Drug Monit1998，20，1：	1
19	Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing显示文摘	Birkert D J Robson R A Grgurinovich N	1990	Ther Drug Monit1990，12，1：	1
20	Carbapenems in pediatrics显示文摘	Ayalew K Nambiar S Yasinskaya Y	2003	Ther Drug Monit2003，25，5：	1

返回顶部每页显示：

共76页首页上一页第1页下一页末页 /76 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示